|
fumiquinazoline C |
44 |
0.41 |
0.36 |
0.55 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@@H]1N[C@H]2N(C1=O)c1ccccc1[C@@]21C[C@@H]2C(=O)N[C@](C)(O1)c1nc3ccccc3c(=O)n12 |
view |
fumiquinazoline C |
|
|
(-)-Mellein |
0 |
0.58 |
0.45 |
0.83 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@@H]1Cc2cccc(O)c2C(=O)O1 |
view |
(-)-Mellein |
|
|
fusaric acid |
1 |
0.56 |
0.4 |
0.81 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCCCc1ccc(C(=O)O)nc1 |
view |
fusaric acid |
|
|
azaspirene |
9 |
0.5 |
0.47 |
0.65 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC/C=C/C=C/C1=C(C)C(=O)C2(O1)C(=O)N[C@@](O)(Cc1ccccc1)[C@@H]2O |
view |
azaspirene |
|
|
Legioliulin |
10 |
0.49 |
0.38 |
0.69 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
O=c1oc(/C=C/C=C/c2ccccc2)cc2cccc(O)c12 |
view |
Legioliulin |
|
|
marinacarboline c |
11 |
0.49 |
0.42 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(=O)c1nc(C(=O)NCCc2ccccc2)cc2c1[nH]c1ccccc12 |
view |
marinacarboline c |
|
|
1,6-dihydro-8-propylanthraquinone |
12 |
0.49 |
0.41 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCCc1cc(O)cc2c1C(=O)c1c(O)cccc1C2=O |
view |
1,6-dihydro-8-propylanthraquinone |
|
|
6-methylsalicyclic acid |
2 |
0.52 |
0.37 |
0.76 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
Cc1cccc(O)c1C(=O)O |
view |
6-methylsalicyclic acid |
|
|
Xenocyloin A |
3 |
0.52 |
0.45 |
0.7 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)C(=O)[C@@H](O)Cc1c[nH]c2ccccc12 |
view |
Xenocyloin A |
|
|
albonoursin |
4 |
0.52 |
0.48 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O |
view |
albonoursin |
|
|
huperzine A |
5 |
0.51 |
0.38 |
0.74 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C1\C2C=C(C)CC1(N)c1ccc(=O)[nH]c1C2 |
view |
huperzine A |
|
|
Xenocyloin B |
6 |
0.51 |
0.45 |
0.69 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCC(C)C(=O)[C@@H](O)Cc1c[nH]c2ccccc12 |
view |
Xenocyloin B |
|
|
isopropylstilbene |
7 |
0.51 |
0.47 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)c1c(O)cc(/C=C/c2ccccc2)cc1O |
view |
isopropylstilbene |
|
|
2,5-dialkylresorcinols |
8 |
0.5 |
0.38 |
0.71 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)CCCc1cc(O)c(C(C)C)c(O)c1 |
view |
2,5-dialkylresorcinols |
|
|
thalnumycin A |
14 |
0.48 |
0.39 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCC1C(=O)c2c(cc3cccc(O)c3c2O)CC1(C)O |
view |
thalnumycin A |
|
|
chloramphenicol |
15 |
0.48 |
0.38 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl |
view |
chloramphenicol |
|
|
Xenocyloin C |
16 |
0.48 |
0.41 |
0.66 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(=O)O[C@@H](Cc1c[nH]c2ccccc12)C(=O)C(C)C |
view |
Xenocyloin C |
|
|
Xenocyloin D |
17 |
0.48 |
0.42 |
0.65 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCC(C)C(=O)[C@H](Cc1c[nH]c2ccccc12)OC(C)=O |
view |
Xenocyloin D |
|
|
endophenazine A1 |
18 |
0.48 |
0.4 |
0.65 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(=O)c1cccc2nc3cccc(C/C=C(\C)CO)c3nc12 |
view |
endophenazine A1 |
|
|
Xenortide C |
19 |
0.48 |
0.47 |
0.61 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CN[C@H](C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCc1ccccc1)C(C)C |
view |
Xenortide C |
|
|
Xenortide A |
20 |
0.48 |
0.47 |
0.6 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CN[C@@H](CC(C)C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCc1ccccc1 |
view |
Xenortide A |
|
|
Endophenazine A |
21 |
0.47 |
0.38 |
0.66 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)=CCc1cccc2nc3cccc(C(=O)[O-])c3nc12 |
view |
Endophenazine A |
|
|
ochratoxin A |
22 |
0.47 |
0.43 |
0.61 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(=O)O)c(O)c2C(=O)O1 |
view |
ochratoxin A |
|
|
Sevadicin |
23 |
0.47 |
0.46 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(NC(=O)C(N)Cc1ccccc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O |
view |
Sevadicin |
|
|
5-Acetyl-5,10-dihydrophenazine-1-carboxylic acid |
24 |
0.47 |
0.5 |
0.56 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(=O)c1cccc2c1Nc1ccccc1N2C(C)=O |
view |
5-Acetyl-5,10-dihydrophenazine-1-carboxylic acid |
|
|
K1115A |
25 |
0.46 |
0.37 |
0.64 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCCc1c(C(=O)O)c(O)cc2c1C(=O)c1c(O)cccc1C2=O |
view |
K1115A |
|
|
brevianamide F |
26 |
0.46 |
0.37 |
0.64 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N2CCC[C@@H]12 |
view |
brevianamide F |
|
|
9-deoxy tilivalline |
27 |
0.46 |
0.38 |
0.63 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
O=C1c2ccccc2N[C@@H](c2c[nH]c3ccccc23)[C@@H]2CCCN12 |
view |
9-deoxy tilivalline |
|
|
pseurotin |
28 |
0.46 |
0.4 |
0.62 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC/C=C\[C@H](O)[C@H](O)C1=C(C)C(=O)[C@]2(O1)C(=O)N[C@@](OC)(C(=O)c1ccccc1)[C@@H]2O |
view |
pseurotin |
|
|
Xenortide D |
29 |
0.46 |
0.43 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CN[C@H](C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCc1c[nH]c2ccccc12)C(C)C |
view |
Xenortide D |
|
|
haliamide |
30 |
0.46 |
0.49 |
0.56 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C=CC(C)C/C(C)=C/C=C/C(C)NC(=O)c1ccccc1 |
view |
haliamide |
|
|
barbamide |
31 |
0.46 |
0.47 |
0.56 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO/C(=C/C(=O)N(C)C(Cc1ccccc1)c1nccs1)CC(C)C(Cl)(Cl)Cl |
view |
barbamide |
|
|
5-(2-Hydroxyacetyl)-5,10-dihydrophenazine-1-carboxylic acid |
32 |
0.46 |
0.48 |
0.55 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(=O)c1cccc2c1Nc1ccccc1N2C(=O)CO |
view |
5-(2-Hydroxyacetyl)-5,10-dihydrophenazine-1-carboxylic acid |
|
|
Benzylpenicillin |
33 |
0.46 |
0.51 |
0.53 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+] |
view |
Benzylpenicillin |
|
|
Obafluorin |
34 |
0.45 |
0.37 |
0.63 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
O=C(N[C@@H]1C(=O)O[C@@H]1Cc1ccc([N+](=O)[O-])cc1)c1cccc(O)c1O |
view |
Obafluorin |
|
|
lorneic acid A |
35 |
0.45 |
0.37 |
0.62 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCCC/C=C/c1cc(C)ccc1/C=C/CC(=O)O |
view |
lorneic acid A |
|
|
Hapalosin |
36 |
0.45 |
0.4 |
0.6 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCCCCCC[C@H]1OC(=O)C[C@@H](O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](C(C)C)OC(=O)[C@H]1C |
view |
Hapalosin |
|
|
Xenortide B |
37 |
0.45 |
0.43 |
0.58 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CN[C@@H](CC(C)C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCc1c[nH]c2ccccc12 |
view |
Xenortide B |
|
|
AK-toxin |
38 |
0.44 |
0.38 |
0.6 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(=O)NC(C(=O)OC(/C=C/C=C\C=C\C(=O)O)C1(C)CO1)C(C)c1ccccc1 |
view |
AK-toxin |
|
|
endophenazine G |
39 |
0.44 |
0.39 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(=O)c1cccc2nc3cccc(/C=C/C(C)(C)O)c3nc12 |
view |
endophenazine G |
|
|
cytochalasin K |
40 |
0.43 |
0.38 |
0.57 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC1=C(C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)O/C=C\[C@@](C)(O)C(=O)[C@@H](C)C/C=C\[C@H]3[C@@H]1O |
view |
cytochalasin K |
|
|
cytochalasin E |
41 |
0.43 |
0.38 |
0.57 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@H]1C/C=C\[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4ccccc4)NC(=O)[C@@]23OC(=O)O/C=C\[C@@](C)(O)C1=O |
view |
cytochalasin E |
|
|
roquefortine C |
42 |
0.42 |
0.37 |
0.57 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C=CC(C)(C)C12CC3C(=O)NC(=Cc4cnc[nH]4)C(=O)N3C1Nc1ccccc12 |
view |
roquefortine C |
|
|
fumiquinazoline A |
43 |
0.41 |
0.37 |
0.55 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@@H]1N[C@H]2N(C1=O)c1ccccc1[C@@]2(O)C[C@@H]1C(=O)N[C@@H](C)c2nc3ccccc3c(=O)n21 |
view |
fumiquinazoline A |
|
|
benzoxazinone DIMBOA |
45 |
0.41 |
0.38 |
0.53 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
COc1ccc2c(c1)OC(O)C(=O)N2O |
view |
benzoxazinone DIMBOA |
|
|
andrimid |
46 |
0.4 |
0.36 |
0.53 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C/C=C/C=C/C(=O)N[C@@H](CC(=O)N[C@H](C(=O)[C@@H]1C(=O)NC(=O)[C@H]1C)C(C)C)c1ccccc1 |
view |
andrimid |
|
|
phenalamide |
47 |
0.39 |
0.37 |
0.5 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(/C=C/C=C/C=C/C=C(\C)C(=O)NC(C)CO)=C\C(C)C(O)/C(C)=C/C(C)CCc1ccccc1 |
view |
phenalamide |
|
|
Rhabdopeptide 1 |
48 |
0.38 |
0.4 |
0.46 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CN[C@@H](CC(C)C)C(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](C(=O)NCCc1ccccc1)C(C)C)C(C)C)C(C)C |
view |
Rhabdopeptide 1 |
|
|
Rhabdopeptide 2 |
49 |
0.38 |
0.4 |
0.45 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CN[C@@H](C(=O)N(C)[C@H](CC(C)C)C(=O)N(C)[C@@H](C(=O)N(C)[C@@H](C(=O)NCCc1ccccc1)C(C)C)C(C)C)C(C)C |
view |
Rhabdopeptide 2 |
|
|
indolmycin |
13 |
0.49 |
0.4 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CNC1=NC(=O)C(C(C)c2c[nH]c3ccccc23)O1 |
view |
indolmycin |
|